Try our Advanced Search for more refined results
Health
-
December 23, 2025
Squires Will Review If Hydrafacial's ITC Win Should End IPR
U.S. Patent and Trademark Office Director John Squires has paused the Patent Trial and Appeal Board's review of a Hydrafacial LLC skin treatment patent to consider the effect of a related U.S. International Trade Commission decision.
-
December 23, 2025
Top North Carolina Cases Of 2025
A sweep of settlements in major lawsuits punctuated the second half of the year in North Carolina, from a record-breaking wrongful death deal to an eleventh-hour resolution in a lending fight over a biogas development project. Here are some of the top North Carolina case outcomes in the second half of 2025.
-
December 23, 2025
'Surprise' Expert Prompts Axing Of $14M Car Crash Verdict
A California appellate court has vacated a $13.8 million jury verdict after finding that the trial court abused its discretion by allowing a "surprise" medical expert witness to testify at an auto collision trial, saying his testimony likely affected the jury's substantial award.
-
December 23, 2025
Connecticut's Most Notable Cases Of 2025
Two attorneys who were licensed in Connecticut were convicted in 2025 on charges that either did or could result in prison time, including a longtime real estate attorney who fatally shot a man in his law firm's parking lot. And the state's largest healthcare system said it would pay $45 million to exit an agreement to buy three ailing hospitals that were in much worse condition than previously known. Here's a look back at three of the top cases of 2025.
-
December 23, 2025
DHS Finalizes Rule Shifting H-1B Odds To Higher Earners
The Trump administration finalized changes to the H-1B lottery Tuesday, unveiling a final rule it said will favor higher-paid and higher-skilled positions and tamp down on employers exploiting the program to hire low-wage workers and depress the wages of U.S. workers.
-
December 23, 2025
Blue Cross Seeks McDonald Hopkins' Fraud Warning Docs
Advice that McDonald Hopkins LLC gave a Florida hospital manager about potential exposure to criminal prosecution for healthcare fraud is neither privileged nor work product, and so should be handed over to a Blue Cross health insurer being sued for malicious prosecution in Georgia federal court, the insurer said.
-
December 23, 2025
Sanofi Eczema Drug Linked To Lymphoma, Suit Says
Drug manufacturers Regeneron Pharmaceuticals and Sanofi were hit with a lawsuit Monday from a Georgia woman alleging the companies have covered up a "strong and consistent causal relationship" between their drug Dupixent and a form of non-Hodgkins lymphoma.
-
December 23, 2025
Patients Say Pa. Med Mal Firm Left Data Vulnerable To Hackers
A Pittsburgh law firm that handles medical malpractice and insurance litigation faces a proposed class action complaint alleging that it failed to protect the private health and personal data of patients whose information was stolen in a data breach.
-
December 23, 2025
11th Circ. Asked To Rehear Pregnancy Center Vandalism Case
A Florida woman convicted of vandalizing crisis pregnancy centers across the state asked the Eleventh Circuit Monday to reconsider a ruling affirming her conviction, arguing that she should not have been prosecuted under a conspiracy statute for violating the Freedom of Access to Clinic Entrances Act.
-
December 23, 2025
Johnson & Johnson Hit With $1.5B Talc Verdict In Baltimore
A Baltimore jury late Monday returned a walloping verdict of more than $1.5 billion in favor of a woman who claimed that Johnson & Johnson talc products caused her mesothelioma, which her attorneys say is the largest verdict against the company for a single plaintiff.
-
December 22, 2025
Becton Muscles Out Hernia Mesh Rivals, Antitrust Suit Says
Tela Bio Inc. slapped Becton Dickinson and Co. and its subsidiaries with an antitrust lawsuit Friday in Pennsylvania federal court accusing the medical tech giant of abusing its dominant position in the hernia mesh market to block Tela's product and keep Becton's "costlier and clinically inferior" mesh on hospital shelves in the U.S.
-
December 22, 2025
Nev. Dental Group Strikes $3.3M Deal In Data Breach Suit
A Nevada-based dental practice agreed on Friday to pay $3.3 million to resolve proposed class claims over a data breach that potentially affected over 1.2 million people, the plaintiffs said in a request to a federal court for preliminary approval of the deal.
-
December 22, 2025
Hochul Signs AG James' Bill To Expand Consumer Law
New York Gov. Kathy Hochul has signed into law New York Attorney General Letitia James' legislation to expand the state's ban on deceptive business practices to also protect against unfair and abusive practices, in the first updates to the state's primary consumer protection law in 45 years.
-
December 22, 2025
DOJ, SEC Charge 6 In $41M Insider Trading Scheme
Federal prosecutors in New Jersey have charged six people in connection with what the government is alleging are securities fraud schemes that led to at least $41 million in illicit profits from insider trading, as well as gains from manipulating the stock prices of biopharmaceutical companies.
-
December 22, 2025
Supreme Court Halts Pittsburgh Post-Gazette Union Order
The U.S. Supreme Court stayed a Third Circuit order Monday that had required the Pittsburgh Post-Gazette to bargain in good faith with its newsroom workers' union and rescind changes to their healthcare and working conditions, pressing pause on an order that ended a three-year strike at the paper.
-
December 22, 2025
6th Circ. Vacates Pharma Salesman's $6.8M Restitution Order
The Sixth Circuit vacated a nearly $7 million restitution order against a pharmaceutical salesman convicted of healthcare fraud, finding an Ohio federal court erred in calculating that amount and apportioning liability.
-
December 22, 2025
Ed Dept. Ordered To Restore $1B In Mental Health Grants
The U.S. Department of Education will not be allowed to cut more than $1 billion in mental health grants for schools after a Washington federal judge ruled that the agency acted illegally by citing new, undisclosed Trump administration priorities as a basis for slashing the funding.
-
December 22, 2025
New Class Action Claims CIBC, RBC Rigged Quantum Shares
A Quantum Biopharma investor has filed a proposed class action against several major Canadian banks, accusing them of running a spoofing scheme for years that artificially drove down Quantum's stock price — flooding exchanges with fake sell orders to mislead the market and buy shares at deflated prices, costing ordinary shareholders millions.
-
December 19, 2025
J&J Hit With $66M Verdict In Minnesota Mom's Asbestos Case
A Minnesota jury Friday awarded a mother of three $65.5 million following a 13-day trial in her lawsuit that claimed Johnson & Johnson's talc products exposed her to asbestos and contributed to cancer in her abdominal lining, the mother's attorneys announced.
-
December 19, 2025
Feds Fight 'Do-Over' Of Tort Atty's Attempted-Extortion Rap
Federal prosecutors are urging the Fourth Circuit not to give "a do-over" to a medical malpractice attorney who was convicted of attempting to extort the University of Maryland Medical System out of $25 million and who says his self-representation at trial was not competent.
-
December 19, 2025
Trump's Cannabis Order: The Impact On Hemp And Research
President Donald Trump's executive order Thursday reignited an administrative process to reclassify marijuana as a less restricted drug, but its provisions touching on cannabis research and hemp-derived CBD are less obvious.
-
December 19, 2025
Health Co. CEO Gets 15 Years In $1.4B Fraud Scheme
A Florida federal judge sentenced a software company CEO to 15 years in prison Friday for participating in a scheme to coordinate illegal medical kickbacks through an internet platform, an operation that resulted in $1.4 billion worth of false billings to Medicare and other insurers for unnecessary medical products.
-
December 19, 2025
Michigan's 5 Biggest Court Rulings Of 2025
Michigan courts had a memorable year in 2025, issuing rulings that extended protections against automatic life sentences to young adults, struck down abortion restrictions and pulled the plug on criminal cases related to President Donald Trump's so-called fake elector plot.
-
December 19, 2025
AstraZeneca Unit Ducks Patent Fraud, Not Sham Suit Claims
A Massachusetts federal judge spared AstraZeneca unit Alexion on Friday from half of a nonprofit insurer's proposed class action, finding the plaintiff too far removed from anticompetitive patent fraud that allegedly propped up blood disorder treatment Soliris, while preserving accusations that Alexion brought sham infringement allegations against would-be rivals.
-
December 19, 2025
Squires Issues 21 More Patent Review Denials
U.S. Patent and Trademark Office Director John Squires has denied 21 requests for America Invents Act patent reviews, while not agreeing to institute any new proceedings.
Expert Analysis
-
Patent Ambiguity Persists After Justices Nix Eligibility Appeal
The Supreme Court recently declined to revisit the contentious framework governing patent eligibility by denying certiorari in Audio Evolution Diagnostics v. U.S., suggesting a necessary recalibration of both patent application and litigation strategies, say attorneys at Skadden.
-
Texas Med Spas Must Prepare For 2 New State Laws
Two new laws in Texas — regulating elective intravenous therapy and reforming healthcare noncompetes — mark a pivotal shift in the regulatory framework for medical spas in the state, which must proactively adapt their operations and contractual practices, says Brad Cook at Munsch Hardt.
-
Series
Playing Soccer Makes Me A Better Lawyer
Soccer has become a key contributor to how I approach my work, and the lessons I’ve learned on the pitch about leadership, adaptability, resilience and communication make me better at what I do every day in my legal career, says Whitney O’Byrne at MoFo.
-
Strategies For Cos. Navigating US-Indian Pharma Partnerships
Recent policy adjustments implemented by the U.S. government present both new opportunities and heightened regulatory scrutiny for the Indian life sciences industry, amplifying the importance of collaboration between the Indian and U.S. pharmaceutical sectors, say Bryant Godfrey at Foley Hoag and Jashaswi Ghosh at Holon Law Partners.
-
DOJ-HHS Collab Crystallizes Focus On Health Enforcement
The recently announced partnership between the U.S. Department of Justice and U.S. Department of Health and Human Services to combat False Claims Act violations, following a multiyear trend of high-dollar DOJ recoveries, signals a long-term enforcement horizon with major implications for healthcare entities and whistleblowers, say attorneys at RJO.
-
Series
Law School's Missed Lessons: Learning From Failure
While law school often focuses on the importance of precision, correctness and perfection, mistakes are inevitable in real-world practice — but failure is not the opposite of progress, and real talent comes from the ability to recover, rethink and reshape, says Brooke Pauley at Tucker Ellis.
-
How The Healthline Privacy Settlement Redefines Ad Tech Use
The Healthline settlement is the first time California has drawn a clear line in the sand around how website tracking must function in practice, so if your site uses tracking technologies, especially around sensitive content like health or finance, regulators are inspecting your website's back end, not just its banner, say attorneys at Baker Donelson.
-
How Sweeping Budget Bill Shakes Up Health Industry
With the recently passed One Big Beautiful Bill Act marking one of the most significant overhauls of federal health policy since the passage of the Affordable Care Act, providers, managed care organizations and life sciences companies must now shift focus from policy review to implementation planning, say advisers at Holland & Knight.
-
Series
Adapting To Private Practice: From ATF Director To BigLaw
As a two-time boomerang partner, returning to BigLaw after stints as a U.S. attorney and the director of the Bureau of Alcohol, Tobacco, Firearms and Explosives, people ask me how I know when to move on, but there’s no single answer — just clearly set your priorities, says Steven Dettelbach at BakerHostetler.
-
New DOJ Penalty Policy Could Spell Trouble For Cos.
In light of the U.S. Department of Justice’s recently published guidance making victim relief a core condition of coordinated resolution crediting, companies facing parallel investigations must carefully calibrate their negotiation strategies to minimize the risk of duplicative penalties, say attorneys at Debevoise.
-
A Look At Key 5th Circ. White Collar Rulings So Far This Year
In the first half of 2025, the Fifth Circuit has decided numerous cases of particular import to white collar practitioners, which collectively underscore the critical importance of meticulous recordbuilding, procedural compliance and strategic litigation choices at every stage of a case, says Joe Magliolo at Jackson Walker.
-
High Court Cert Spotlights Varying Tests For Federal Removal
A recent decision by the U.S. Supreme Court to review Chevron v. Plaquemines Parish, a case involving the federal officer removal statute, highlights three other recent circuit court decisions raising federal removal questions, and serves as a reminder that defendants are the masters of removal actions, says Varun Aery at Hollingsworth.
-
Series
Playing Baseball Makes Me A Better Lawyer
Playing baseball in college, and now Wiffle ball in a local league, has taught me that teamwork, mental endurance and emotional intelligence are not only important to success in the sport, but also to success as a trial attorney, says Kevan Dorsey at Swift Currie.
-
What US Medicine Onshoring Means For Indian Life Sciences
Despite the Trump administration's latest moves to onshore essential medicine manufacturing, India will likely remain an indispensable component of the U.S. drug supply chain, but Indian manufacturers should prepare for stricter compliance checks, says Jashaswi Ghosh at Holon Law Partners.
-
How US Cos. Should Prep For Brazil's Int'l Data Transfer Rules
Brazil's National Data Protection Authority's new rules concerning the processing and storing of Brazilians' personal data carry significant reputational risks for the e-commerce, financial services, education and health sectors, so U.S. companies with business in Brazil should prepare ahead of the Aug. 23 compliance date, says Juliane Chaves Ferreira at Guimarães & Vieira de Mello.